Silver Nanoparticles Selectively Treat Neurofibromatosis Type 1-Associated Malignant Peripheral Nerve Sheath Tumors in a Neurofibromin-Dependent Manner

Silver Nanoparticles Selectively Treat Neurofibromatosis Type 1-Associated Malignant Peripheral Nerve Sheath Tumors in a Neurofibromin-Dependent Manner

Neurofibromatosis type 1 (NF1) is among the most common neurogenic disorders, characterized by loss of function mutations in the neurofibromin gene (<i>NF1</i>). NF1 patients are extremely susceptible to developing neurofibromas, which can transform into deadly malignant peripheral nerve...

Full description

Bibliographic Details
Main Authors: Garrett Alewine, Jerrica Knight, Adithya Ghantae, Christina Mamrega, Bashnona Attiah, Robert A. Coover, Cale D. Fahrenholtz
Format: Article
Language:English
Published: MDPI AG 2022-06-01
Series:Journal of Personalized Medicine
Subjects:
nanomedicine
oncology
silver nanoparticles
malignant peripheral nerve sheath tumors
neurofibromatosis type 1
Online Access:https://www.mdpi.com/2075-4426/12/7/1080

Internet

https://www.mdpi.com/2075-4426/12/7/1080

Similar Items